Altamira Therapeutics Ltd (FRA:2QA)
€ 948 0 (0%) Market Cap: 1.45 Mil Enterprise Value: 1.79 Mil PE Ratio: 0.84 PB Ratio: 0.17 GF Score: 28/100

Q2 2019 Auris Medical Holding Ltd Earnings Call Transcript

Aug 15, 2019 / 12:00PM GMT
Release Date Price: €912.4 (-2.73%)
Operator

Good morning and welcome to the Auris Medical's conference call. On today's call, Thomas Meyer, Auris Medical Chairman and Chief Executive Officer; and Hernan Levett, Auris Medical Chief Financial Officer, will present the company's financial results for the first half 2019 and provide a business update. The accompanying slides can be found on our website in the Investors section.

Earlier today, Auris Medical issued a news release with the first half 2019 financial results as well as a business update. The release is available on the company's website, aurismedical.com, and filed with the SEC.

During today's call, we will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating, financial or business performance or our strategies and expectations. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot